[1]
C. Arepalli and R. Palani, “Low-Dose Alemtuzumab-Based Induction in Kidney Transplantation: A Retrospective Comparison of Maintenance Immunosuppression, Long-Term Graft Outcomes, and Induction Costs”, Adolescência e Saúde, pp. 2735–2739, Oct. 2026.